These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3920977)

  • 1. Toxic oil syndrome, Spain: effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats.
    Suarez A; Viloria MD; Garcia-Barreno P; Municio AM
    Arch Environ Contam Toxicol; 1985 Mar; 14(2):131-6. PubMed ID: 3920977
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome.
    Marquet A; Larraga V; Diez JL; Amela C; Rodrigo J; Muñoz E; Pestaña A
    Experientia; 1984 Sep; 40(9):977-80. PubMed ID: 6205897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleoylanilide, a possible causative agent of toxic oil syndrome, interferes with the cytoskeleton in a neuronal cell line.
    Martínez JL; Behrens MM; Moratilla C; Renart J
    Neurotoxicol Teratol; 1997; 19(2):147-50. PubMed ID: 9136131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic effects of fatty acid anilides on the oxygen defense systems of guinea pig lungs and erythrocytes.
    Mukherjee S; Ghosh S; Rodgers L; Nayyar T; Desai U; Das SK
    J Biochem Toxicol; 1994 Feb; 9(1):1-7. PubMed ID: 8151627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of fatty acid anilides present in toxic oils on the metabolism of exogenous arachidonic acid in cultured human endothelial cells.
    Pich I; López S; Vila L; Lagunas C; de Castellarnau C
    Toxicology; 1993 Jan; 77(1-2):51-63. PubMed ID: 8442018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of 12-hydroxyeicosatetraenoic acid production in mouse lungs following dietary oleic anilide consumption: implications for the toxic oil syndrome.
    Yoshida SH; Bruenner BA; German JB; Gershwin ME
    Arch Environ Contam Toxicol; 1995 May; 28(4):524-8. PubMed ID: 7755405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of cis-fatty acids and their anilides with formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate and dioctanoyl-s,n-glycerol in human leukocytes.
    Heiskanen K; Ruotsalainen M; Savolainen K
    Toxicology; 1995 Dec; 104(1-3):113-21. PubMed ID: 8560489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic oil stimulates collagen synthesis acting at a pretranslational level in cultured fat-storing cells.
    Hernández-Muñoz I; de la Torre MP; Pedraza MA; Sánchez-Alcázar JA; Muñoz-Yagüe MT; Solis-Herruzo JA
    Gastroenterology; 1994 Mar; 106(3):691-701. PubMed ID: 8119541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter changes in cerebrospinal fluid in the Spanish toxic oil syndrome: human clinical findings and experimental results in mice.
    del Ser T; Franch O; Portera A; Muradas V; Yebenes JG
    Neurosci Lett; 1986 Jun; 67(2):135-40. PubMed ID: 2425298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic vascular toxicity and fatty acid anilides in the toxic oil syndrome.
    Boor PJ; Khan MF; Kaphalia BS; Jerrells TR; Ansari GA
    J Am Coll Cardiol; 1991 Dec; 18(7):1824-8. PubMed ID: 1960335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic oil syndrome.
    Spurzem JR; Lockey JE
    Arch Intern Med; 1984 Feb; 144(2):249-50. PubMed ID: 6696556
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary oil related to the toxic oil syndrome on the lipids of guinea pig liver microsomes.
    de la Casa E; Pérez-González N; Sánchez-Bernal C; Llanillo M
    Lipids; 1995 Jun; 30(6):575-9. PubMed ID: 7651086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hill reaction produced by fatty acid anilides.
    Sanz P; Carrasco MJ; Repetto M
    Bull Environ Contam Toxicol; 1987 Apr; 38(4):602-9. PubMed ID: 3567397
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of the alimentary toxic oil syndrome due to ingestion of denatured rapeseed oil.
    Gilsanz V; Alvarez JL; Serrano S; Simón J
    Arch Intern Med; 1984 Feb; 144(2):254-6. PubMed ID: 6696559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital tuft alterations in toxic oil syndrome.
    Alonzo-Ruiz A; Zea-Mendoza AC; González-Lanza M; Gómez-Catalán E
    Lancet; 1984 Sep; 2(8401):520-1. PubMed ID: 6147578
    [No Abstract]   [Full Text] [Related]  

  • 18. Esophagus and toxic oil syndrome.
    Abaitua Borda I; Posada de la Paz M; Diaz de Rojas F; Castro Garcia M; Tabuenca Oliver JM; Alonso Gordo JM
    Dig Dis Sci; 1986 Apr; 31(4):443. PubMed ID: 3956341
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercoagulable states and the toxic oil syndrome.
    Castro García M; Posada M; Diaz de Rojas F; Abaitua Borda I; Tabuenca Oliver JM
    Ann Intern Med; 1986 May; 104(5):730. PubMed ID: 3963676
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
    Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
    Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.